Drug
Regadenoson clinical trials
Also written Lexiscan and CVT3146.
- studies test it
- 49
- open now
- 4
- in phase 3
- 4
- first study started
- 2003
Keep track of what changes. Save the regadenoson studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
49 studies that test it; most in 2009 (11)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 11 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 5
- Phase 1
- 8
- Phase 2
- 9
- Phase 3
- 4
- Phase 4
- 14
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 39
University of Maryland, Baltimore (3) · Astellas Pharma Inc (3) · University of Chicago (3) · University of Utah (3) · Gilead Sciences (3) · Emory University (2) · University of Nebraska (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)
Often tested with
Tested in the same studies.
Adenosine (5) · Water O-15 (2) · FS 069 (1) · Gadofosveset trisodium (1) · Temozolomide (1) · Exercise Pain Management (1) · NH-3 (1) · Dobutamine (1)
Studies
Open first, then newest update. How each study uses regadenoson is read from its arms, and is right about nine times in ten.
Testing it · 49
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)RecruitingEarly Phase 1University of UtahNCT04600115Written as Regadenoson
- A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsRecruitingPhase 1/2GE HealthcareNCT04604782Written as Regadenoson
- Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PETRecruitingPhase 2St. Jude Children's Research HospitalNCT05583721Written as Lexiscan
- Allograft Dysfunction in Heart TransplantRecruitingPhase 4Paul KimNCT03102125Written as Regadenoson
- The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPICompletedNot applicableEmory UniversityNCT04316676Written as Regadenoson
- Treat COVID-19 Patients With RegadenosonCompletedPhase 1/2University of Maryland, BaltimoreNCT04606069Written as Regadenoson
- Regadenoson R-T Perfusion Imaging TrialCompletedPhase 1University of NebraskaNCT00837369Written as Regadenoson
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)CompletedPhase 2Astellas Pharma IncNCT01334918Written as regadenoson
- Regadenoson Real Time Perfusion Imaging Trial-OptisonCompletedPhase 3University of NebraskaNCT01489176Written as Regadenoson; Optison
- Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle TrackingCompletedPhase 4M.D. Anderson Cancer CenterNCT02130453Written as Regadenoson
- Regadenoson Infusion of Marginalized Donor Lungs in an EVLP SystemCompletedEarly Phase 1University of Maryland, BaltimoreNCT04521569Written as Regadenoson
- Microvascular Blood Flow in Sickle Cell AnemiaCompletedNot applicableVersitiNCT01566890Written as regadenoson infusion with contrast-enhanced ultrasound
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03971734Written as Regadenoson 0.05mg
- Heart Rate Response to Regadenoson and Sudden Cardiac DeathCompletedNot applicableUniversity of Alabama at BirminghamNCT01842035Written as regadenoson
- Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress TestingCompletedNot applicableUniversity of Maryland, BaltimoreNCT01026012Written as regadenoson
- Stress Testing and Cardiac Magnetic ResonanceCompletedPhase 4University of ChicagoNCT00871260Written as regadenoson
- Stress CT Perfusion in Patients With Chest PainCompletedNot applicableUniversity of ChicagoNCT01969916Written as Regadenoson
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEFCompletedPhase 4Marvin W. Kronenberg, M.D.NCT02589977Written as regadenoson
- Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionTerminatedNot applicableNational Jewish HealthNCT02220634Written as Regadenoson
- Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow ReserveTerminatedPhase 4Duke UniversityNCT03249272Written as Regadenoson
See all 49 studies that test regadenoson →
Given in every arm · 5 — regadenoson is usual care beside what is tested
- Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)CompletedPhase 3Astellas Pharma IncNCT00826280Written as regadenoson
- A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCITerminatedPhase 2SanofiNCT03236311Written as Regadenoson
- Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal VolunteersCompletedPhase 1University of MichiganNCT01433705Written as Regadenoson
- Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion StudiesCompletedNot applicableDaniel S. BermanNCT01949844Written as regadenoson
- The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in VivoStatus unknownPhase 2University of AarhusNCT03090087Written as Regadenoson
Codes
What other systems call regadenoson · ClinicalTrials.gg INT004359
- MeSH (NLM) C430916regadenosonConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2XLN4Y044HREGADENOSONConfirmed FDA, NLM, Wikidata
- RxNorm 640062One source FDA
- Wikidata Q83118320Regadenoson hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74420RegadenosonOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C430916 | regadenoson | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2XLN4Y044H | REGADENOSON | Confirmed FDA, NLM, Wikidata |
| RxNorm | 640062 | — | One source FDA |
| Wikidata | Q83118320 | Regadenoson hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74420 | Regadenoson | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.